Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer (Q74300566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

6

Wolfgang Schlegel

0 references

author name string

Sabine Levegrün

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Andrew Jackson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ennapadam S Venkatraman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Mark W Skwarchuk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Wolfgang Schlegel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Zvi Fuks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Steven A Leibel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Clifton Ling

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

11-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

Does Variation in thein VitroCellular Radiosensitivity Explain the Shallow Clinical Dose—control Curve for Malignant Melanoma?

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Dosimetric Precision Requirements in Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Dose, volume, and tumor-control predictions in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

An approach to the interpretation of clinical data on the tumour control probability-dose relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Bootstrap Methods: Another Look at the Jackknife

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Analysis of clinical complication data for radiation hepatitis using a parallel architecture model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

A comprehensive three-dimensional radiation treatment planning system.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Radiation dose-response of human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Tumor radioresistance in clinical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Clinical implications of heterogeneity of tumor response to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Optimum parameters in a model for tumour control probability including interpatient heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Tumor control probability of nasopharyngeal carcinoma: a comparison of different mathematical models.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Inter-tumor heterogeneity and radiation dose-control curves

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2802%2900062-2

7 January 2021

10.1016/S0167-8140(02)00062-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12065099%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference